Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AA, AAD, AbbVie, abrocitinib, accredited, acne, adagrasib, aesthetic, affinity, amplified, antitumor, assumption, auremolimab, autoreactive, Belgium, biotech, Broadly, CALR, calreticulin, CIBINQO, CMS, Cut, Cyclin, depigmenting, deplete, diagnostic, dissolution, domestic, Edmund, Erosion, erythema, escalation, ESG, excise, exempt, extremely, featured, forthcoming, geopolitical, Harrigan, hesitancy, highlighted, Hispanic, indirect, instability, introduced, kipping, lichen, lymphoid, mAb, macroeconomic, Maruho, mCALR, memory, Mirati, mucosal, multinational, mutant, NMPA, nonsegmental, notified, novo, obsolescence, oncoprotein, Orange, PBM, phototherapy, Plenary, portal, povorcitinib, purple, pyrexia, reimposed, repealed, replication, Republic, resident, retaliatory, RINVOQ, Russian, serine, Session, shrinkage, Southeast, Spain, speaking, steroid, Swissmedic, threonine, TRM, Ukraine, unfavorable, unfavorably, upadacitinib, urinary, usable, vivo, women, zilurgisertib
Removed:
AML, architectural, ASU, bankruptcy, bargaining, CMC, complementing, constructing, conversion, delivered, Dixon, eliminating, engineering, fedratinib, function, ground, half, indefinite, INREBIC, issuable, jointly, matching, matured, NaN, nominate, opt, pattern, Philadelphia, relief, removed, resourcing, Simplifying, topic, uncured, waiting, Wendy
Filing tables
Filing exhibits
Related press release
Associated INCY transcripts
INCY similar filings
Filing view
External links